Relmada Therapeutics Reports Q2 2026 Financial Results

What Happened
Relmada Therapeutics, Inc. (RLMD) issued a press release on August 6, 2026 providing a corporate update and reporting its financial results for the three and six months ended June 30, 2026. The company announced a conference call and audio webcast on Thursday, August 6, 2026 at 4:30 PM EST / 1:30 PM PST to discuss the update and results. Relmada stated that its complete unaudited condensed consolidated financial statements and related notes as of June 30, 2026 and December 31, 2025 (and for the three- and six-month periods ended June 30, 2026 and 2025) will be included in its Quarterly Report on Form 10-Q.

Key Details

• Press release with the corporate update and Q2 2026 results was furnished as Exhibit 99.1 to the Form 8-K (filed Aug 6, 2026).
• Updated corporate presentation was furnished as Exhibit 99.2 (filed Aug 6, 2026).
• Conference call and webcast occurred Aug 6, 2026 at 4:30 PM ET / 1:30 PM PT to review results.
• Complete unaudited condensed consolidated financial statements and notes will appear in the company’s forthcoming Form 10-Q.

Why It Matters
This 8-K signals Relmada’s formal release of its quarterly earnings and a management update, and schedules a live call where investors can hear management’s commentary. The full financial details and footnotes will be available in the 10-Q — until that filing, investors have the press release and presentation to gauge near-term performance and company messaging. Keywords: earnings, quarterly results, corporate update, webcast, Form 10-Q.